ArticleBlood advances2017

Erratum: Field JJ, Majerus E, Gordeuk VR, et al. Randomized phase 2 trial of regadenoson for treatment of acute vaso-occlusive crises in sickle cell disease.

PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.